Download
dialysis and replacement solutions for crrt n.
Skip this Video
Loading SlideShow in 5 Seconds..
Dialysis and Replacement Solutions for CRRT PowerPoint Presentation
Download Presentation
Dialysis and Replacement Solutions for CRRT

Dialysis and Replacement Solutions for CRRT

1432 Views Download Presentation
Download Presentation

Dialysis and Replacement Solutions for CRRT

- - - - - - - - - - - - - - - - - - - - - - - - - - - E N D - - - - - - - - - - - - - - - - - - - - - - - - - - -
Presentation Transcript

  1. Dialysis and Replacement Solutions for CRRT Jordan M. Symons, MD University of Washington School of Medicine Children’s Hospital & Regional Medical Center Seattle, WA jordan.symons@seattlechildrens.org

  2. CRRT Solutions:Outline of the Talk • Purpose of solutions in CRRT • Goals for a CRRT solution • Description of solutions currently available for CRRT • Considerations in choosing a solution for CRRT

  3. First CAVH Circuit Kramer, P, et al. Arteriovenous haemofiltration: A new and simple method for treatment of over-hydrated patients resistant to diuretics. Klin Wochenschr 55:1121-2, 1977.

  4. CRRT Machines: Current Generation

  5. Convective Clearance To increase clearance by convection, increase ultrafiltration rate (will require more replacement fluids)

  6. D Diffusive Clearance To increase clearance by diffusion, increase dialysate flow rate

  7. Characteristics of the Ideal CRRT Solution • Physiological • Reliable • Inexpensive • Easy to prepare • Simple to store • Quick to the bedside • Widely available • Fully compatible

  8. Base in CRRT Solutions • Hemodialysis: first acetate, then bicarbonate • Peritoneal dialysis: lactate in North America; bicarbonate in Europe • CRRT: lactate or bicarbonate?

  9. Bicarbonate vs. Lactate in CRRT • Both can be used for base • Bicarbonate superior to acetate in HD • PD uses lactate due to technical issues Is bicarbonate preferable to lactate?

  10. Bicarbonate vs. Lactate in CRRT:Blood Lactate Levels Zimmerman et al, Neph, Dial & Transpl 1999 14:2387-2391

  11. Bicarbonate vs. Lactate in CRRT:Blood Lactate Levels in Children Maxvold et al, Blood Purif 17:#27, 1999 [abstract]

  12. Bicarbonate vs. Lactate in CRRT: Cardiovascular Events Bicarbonate Lactate Barenbrock M et al, Kid Int 58:1751-1757, 2000

  13. Options for CRRT Solutions • Peritoneal dialysate • Adapted pre-made solutions • Saline, Lactated Ringers • Multi-bag systems • Custom-made solutions • Local pharmacy; outsource • On-line dialysate • Commercially available CRRT solutions

  14. Baxter Hemofiltration Solution • Lactate buffered • 5 liter bag • Small amount of potassium • Contains calcium

  15. Chemical Content of Baxter Hemofiltration Solution

  16. Hemosol (Hospal) • 5 liter bag • “L” series (lactate) with variable K+, glucose • “B0” (bicarbonate) needs to be mixed • Not available in US

  17. Chemical Content of Hemosol

  18. Normocarb (DSI) • Bicarbonate buffered • Concentrate must be compounded • Final volume 3.24 liters (240ml concentrate added to 3 L bag)

  19. Chemical Content of Normocarb

  20. PrismaSate (Gambro) • Bicarbonate buffered • Small amount of lactate • 5 liter bag • 2 compartments to prevent precipitation • Two ionic formulations

  21. Chemical Content of PrismaSate

  22. Choosing a Solution: Issues to Consider • Anticoagulation • Cost • CRRT modality • Diffusion (CVVHD) • Convection (CVVH) • Both (CVVHDF) • Patient safety

  23. Anticoagulation and Solutions May need to consider Ca++ content if using citrate for anticoagulation

  24. CRRT Solutions: Costs Bunchman et al, Blood Purif 20: 2002 [abstract]

  25. D R R Modality May Have an Impact on Choice of Solutions • Diffusion requires the use of a dialysate • Convection requires the use of replacement fluids

  26. What’s the Difference BetweenDialysate and Replacement Fluid? Dialysate is a Device Replacement Fluid is a Drug

  27. FDA Approval Status of CRRT Solutions

  28. Normocarb as Replacement Fluid FDA Modernization Act of 1997: “The Act creates a special exemption to ensure continued availability of compounded drug products prepared by pharmacists to provide patients with individualized therapies not available commercially”. Bunchman et al, AJKD 42(6):1248-52, 2000

  29. Evaluation of Errors in Preparation of CRRT Solutions • Survey of 3 Pediatric Listserves: • Pediatric Critical Care • Pediatric Nephrology • Pediatric CRRT • 31 programs responded to query Bunchman et al, Blood Purif 22: 2004 [abstract]

  30. Prevalence and Consequences of Errors in Solution Preparation • 16/31 programs reported errors: • 7 errors in replacement solutions • 9 errors in dialysate solutions • Consequences of improper solutions • 2 deaths • 1 non lethal cardiac arrest • 6 seizures (hypo/hypernatremia) • 7 without complications Bunchman et al, Blood Purif 22: 2004 [abstract]

  31. Policy Changes Resulting from Errors in Solutions • Changed to Normocarb for either replacement or dialysate (11) • Changed to PrismaSate for dialysate (2) • Purchased TPN mixer for solutions (2) • Chemistry lab check of every bag (3) • Bag label check by at least 2 staff (10) Bunchman et al, Blood Purif 22: 2004 [abstract]

  32. CRRT Solutions: Summary • Solutions needed to maximize clearance • Bicarbonate seems superior to lactate • Pharmacy made solutions give greatest flexibility but have increased risks/costs • Several industry-made solutions; none currently approved for replacement • Still no perfect “solution” for this problem

  33. Thanks!